Magyarorszagi Reformatus Egyhaz Bethesda Gyermekkorhaza

The medical center is at the forefront of research in neurology, particularly focusing on seizure disorders. The ongoing studies aim to enhance the understanding and treatment of partial-onset (focal) seizures in pediatric populations.

• Partial-onset (focal) seizures in children
• Safety and efficacy of cenobamate

Through innovative research, the center is contributing to the development of safer and more effective therapeutic options for young patients experiencing seizures.

Specializing in movement disorders, the center is conducting pivotal research on Tourette Syndrome. The focus is on evaluating the efficacy and safety of novel treatments to manage tic severity in affected individuals.

• Tourette Syndrome in adults and adolescents
• Gemlapodect efficacy and safety

This research is instrumental in advancing therapeutic strategies that aim to improve the quality of life for patients with Tourette Syndrome.

The center is deeply involved in the study of epileptic syndromes, with a particular emphasis on Dravet and Lennox-Gastaut Syndromes. Research efforts are directed towards assessing long-term safety and tolerability of adjunctive therapies.

• Dravet Syndrome
• Lennox-Gastaut Syndrome
• Soticlestat as adjunctive therapy

By exploring new treatment avenues, the center is paving the way for improved management of these complex syndromes.

Focusing on Autism Spectrum Disorders (ASD), the center is dedicated to understanding and alleviating irritability associated with autistic disorder in children and adolescents. The research evaluates the long-term safety of innovative treatments.

• Irritability in ASD
• Pimavanserin long-term safety

This research is crucial in developing effective interventions that address behavioral challenges in ASD, enhancing patient care and outcomes.